Modified Reaction Conditions for the Radiosynthesis of ¹¹C‑Labeled Asymmetrical Guanidines and the Automated Radiosynthesis of a [¹¹C]mIBG Analog.

Authors

Jason A Witek, Avery C Allen, Allen F Brooks, Shelbie J Cingoranelli, Jenelle Stauff, Tanpreet Kaur, Xia Shao, Peter J H Scott, David M Raffel

Published in

ACS medicinal chemistry letters. Volume 17. Issue 9. Pages 1948-1955. Sep 10, 2026. Epub Aug 24, 2026.

Abstract

Radiolabeled guanidines such as ^123/131I-labeled meta-iodobenzylguanidine (mIBG) have been widely used in nuclear medicine for imaging of cardiac sympathetic nerves, as well as imaging and treatment of neuroendocrine tumors. For a variety of reasons (e.g., low tumor uptake, suboptimal kinetics), there is a need for second generation guanidines, and the synthesis and evaluation of such radiopharmaceuticals is a long-standing focus of our group. However, to date, the generation of analogues has been limited to other monosubstituted guanidines, while both symmetrical and asymmetrical disubstituted analogues around the guanidine have been largely ignored because of their synthetic challenges. To address this limitation, herein we report general conditions for the synthesis of carbon-11 radiolabeled asymmetric guanidines and show proof-of-concept through the automated radiosynthesis and preclinical evaluation of a novel mIBG analogue.

PMID:
42741634
Bibliographic data and abstract were imported from PubMed on 13 Oct 2026.

Read full publication at:
Please sign in to see all details.

Stats

1-terrible, 9-excellent. How would you rate this publication? Sign in in to submit your rating.

Post a comment

You need to be signed in to post comments. You can sign in here.

Comments

There are no comments yet.